位置:首页 > 蛋白库 > SRS11_HUMAN
SRS11_HUMAN
ID   SRS11_HUMAN             Reviewed;         484 AA.
AC   Q05519; Q5T758; Q8IWE6;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   03-AUG-2022, entry version 197.
DE   RecName: Full=Serine/arginine-rich splicing factor 11;
DE   AltName: Full=Arginine-rich 54 kDa nuclear protein;
DE            Short=p54;
DE   AltName: Full=Splicing factor, arginine/serine-rich 11;
GN   Name=SRSF11; Synonyms=SFRS11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hepatoma;
RX   PubMed=1896467; DOI=10.1073/pnas.88.18.8189;
RA   Chaudhary N., McMahon C., Blobel G.;
RT   "Primary structure of a human arginine-rich nuclear protein that
RT   colocalizes with spliceosome components.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:8189-8193(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH PUF60.
RX   PubMed=10606266; DOI=10.1017/s1355838299991938;
RA   Page-McCaw P.S., Amonlirdviman K., Sharp P.A.;
RT   "PUF60: a novel U2AF65-related splicing activity.";
RL   RNA 5:1548-1560(1999).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207 AND SER-434, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207 AND SER-483, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-414; SER-434;
RP   THR-447; SER-449; SER-464 AND SER-483, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-434; THR-447;
RP   SER-449 AND SER-483, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-212; SER-323;
RP   THR-325; SER-434; SER-456 AND SER-483, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-434 AND SER-449, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-197 AND LYS-211, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May function in pre-mRNA splicing.
CC   -!- SUBUNIT: Interacts with PUF60. {ECO:0000269|PubMed:10606266}.
CC   -!- INTERACTION:
CC       Q05519; Q66PJ3-3: ARL6IP4; NbExp=3; IntAct=EBI-1051785, EBI-10248982;
CC       Q05519; Q66PJ3-4: ARL6IP4; NbExp=3; IntAct=EBI-1051785, EBI-5280499;
CC       Q05519; P14921: ETS1; NbExp=2; IntAct=EBI-1051785, EBI-913209;
CC       Q05519; O43716: GATC; NbExp=3; IntAct=EBI-1051785, EBI-6929453;
CC       Q05519; Q5T013: HYI; NbExp=3; IntAct=EBI-1051785, EBI-749235;
CC       Q05519; Q9UHX1: PUF60; NbExp=6; IntAct=EBI-1051785, EBI-1053259;
CC       Q05519; Q14498: RBM39; NbExp=3; IntAct=EBI-1051785, EBI-395290;
CC       Q05519; Q14498-3: RBM39; NbExp=3; IntAct=EBI-1051785, EBI-6654703;
CC       Q05519; O00560: SDCBP; NbExp=3; IntAct=EBI-1051785, EBI-727004;
CC       Q05519; Q8WXA9: SREK1; NbExp=3; IntAct=EBI-1051785, EBI-1044237;
CC       Q05519; Q92844: TANK; NbExp=3; IntAct=EBI-1051785, EBI-356349;
CC       Q05519; G4XUV3; NbExp=3; IntAct=EBI-1051785, EBI-10177989;
CC       Q05519-2; P30049: ATP5F1D; NbExp=3; IntAct=EBI-11975029, EBI-1049505;
CC       Q05519-2; Q9UI36-2: DACH1; NbExp=3; IntAct=EBI-11975029, EBI-10186082;
CC       Q05519-2; Q68J44: DUSP29; NbExp=3; IntAct=EBI-11975029, EBI-1054321;
CC       Q05519-2; O43716: GATC; NbExp=6; IntAct=EBI-11975029, EBI-6929453;
CC       Q05519-2; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-11975029, EBI-16439278;
CC       Q05519-2; P26367: PAX6; NbExp=3; IntAct=EBI-11975029, EBI-747278;
CC       Q05519-2; Q9UHX1-2: PUF60; NbExp=6; IntAct=EBI-11975029, EBI-11529177;
CC       Q05519-2; Q14498: RBM39; NbExp=5; IntAct=EBI-11975029, EBI-395290;
CC       Q05519-2; O00560: SDCBP; NbExp=3; IntAct=EBI-11975029, EBI-727004;
CC       Q05519-2; Q8WXA9: SREK1; NbExp=6; IntAct=EBI-11975029, EBI-1044237;
CC       Q05519-2; P78362: SRPK2; NbExp=3; IntAct=EBI-11975029, EBI-593303;
CC       Q05519-2; A7MD48: SRRM4; NbExp=3; IntAct=EBI-11975029, EBI-3867173;
CC       Q05519-2; Q05519-2: SRSF11; NbExp=3; IntAct=EBI-11975029, EBI-11975029;
CC       Q05519-2; Q66K41-2: ZNF385C; NbExp=3; IntAct=EBI-11975029, EBI-12055653;
CC       Q05519-2; G4XUV3; NbExp=8; IntAct=EBI-11975029, EBI-10177989;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Note=Colocalizes with spliceosome
CC       components.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q05519-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q05519-2; Sequence=VSP_043376;
CC   -!- SIMILARITY: Belongs to the splicing factor SR family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M74002; AAA35554.1; -; mRNA.
DR   EMBL; AL353771; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06459.1; -; Genomic_DNA.
DR   EMBL; BC040436; AAH40436.1; -; mRNA.
DR   CCDS; CCDS53332.1; -. [Q05519-2]
DR   CCDS; CCDS647.1; -. [Q05519-1]
DR   PIR; A40988; A40988.
DR   RefSeq; NP_001177916.1; NM_001190987.1. [Q05519-2]
DR   RefSeq; NP_004759.1; NM_004768.3. [Q05519-1]
DR   RefSeq; XP_011540729.1; XM_011542427.2.
DR   RefSeq; XP_016858301.1; XM_017002812.1.
DR   RefSeq; XP_016858302.1; XM_017002813.1.
DR   AlphaFoldDB; Q05519; -.
DR   SMR; Q05519; -.
DR   BioGRID; 114709; 187.
DR   CORUM; Q05519; -.
DR   IntAct; Q05519; 43.
DR   MINT; Q05519; -.
DR   STRING; 9606.ENSP00000359988; -.
DR   GlyGen; Q05519; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q05519; -.
DR   PhosphoSitePlus; Q05519; -.
DR   SwissPalm; Q05519; -.
DR   BioMuta; SRSF11; -.
DR   DMDM; 8134672; -.
DR   EPD; Q05519; -.
DR   jPOST; Q05519; -.
DR   MassIVE; Q05519; -.
DR   MaxQB; Q05519; -.
DR   PaxDb; Q05519; -.
DR   PeptideAtlas; Q05519; -.
DR   PRIDE; Q05519; -.
DR   ProteomicsDB; 58334; -. [Q05519-1]
DR   ProteomicsDB; 58335; -. [Q05519-2]
DR   Antibodypedia; 1615; 145 antibodies from 23 providers.
DR   DNASU; 9295; -.
DR   Ensembl; ENST00000370949.2; ENSP00000359987.2; ENSG00000116754.14. [Q05519-1]
DR   Ensembl; ENST00000370950.7; ENSP00000359988.3; ENSG00000116754.14. [Q05519-1]
DR   Ensembl; ENST00000370951.5; ENSP00000359989.1; ENSG00000116754.14. [Q05519-2]
DR   GeneID; 9295; -.
DR   KEGG; hsa:9295; -.
DR   MANE-Select; ENST00000370949.2; ENSP00000359987.2; NM_001350605.2; NP_001337534.1.
DR   UCSC; uc001des.4; human. [Q05519-1]
DR   CTD; 9295; -.
DR   DisGeNET; 9295; -.
DR   GeneCards; SRSF11; -.
DR   HGNC; HGNC:10782; SRSF11.
DR   HPA; ENSG00000116754; Low tissue specificity.
DR   MIM; 602010; gene.
DR   neXtProt; NX_Q05519; -.
DR   OpenTargets; ENSG00000116754; -.
DR   PharmGKB; PA35698; -.
DR   VEuPathDB; HostDB:ENSG00000116754; -.
DR   eggNOG; KOG4676; Eukaryota.
DR   GeneTree; ENSGT00730000110872; -.
DR   InParanoid; Q05519; -.
DR   OrthoDB; 1460556at2759; -.
DR   PhylomeDB; Q05519; -.
DR   TreeFam; TF106266; -.
DR   PathwayCommons; Q05519; -.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72187; mRNA 3'-end processing.
DR   Reactome; R-HSA-73856; RNA Polymerase II Transcription Termination.
DR   SignaLink; Q05519; -.
DR   BioGRID-ORCS; 9295; 684 hits in 1090 CRISPR screens.
DR   ChiTaRS; SRSF11; human.
DR   GeneWiki; SFRS11; -.
DR   GenomeRNAi; 9295; -.
DR   Pharos; Q05519; Tbio.
DR   PRO; PR:Q05519; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q05519; protein.
DR   Bgee; ENSG00000116754; Expressed in visceral pleura and 204 other tissues.
DR   ExpressionAtlas; Q05519; baseline and differential.
DR   Genevisible; Q05519; HS.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; TAS:ProtInc.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034447; SRSF11.
DR   PANTHER; PTHR32343:SF6; PTHR32343:SF6; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00360; RRM; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Isopeptide bond; mRNA processing;
KW   mRNA splicing; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   RNA-binding; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378"
FT   CHAIN           2..484
FT                   /note="Serine/arginine-rich splicing factor 11"
FT                   /id="PRO_0000081939"
FT   DOMAIN          33..113
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REPEAT          247..255
FT                   /note="1"
FT   REPEAT          258..265
FT                   /note="2"
FT   REPEAT          267..274
FT                   /note="3"
FT   REPEAT          275..282
FT                   /note="4"
FT   REPEAT          285..292
FT                   /note="5"
FT   REPEAT          293..300
FT                   /note="6"
FT   REPEAT          302..309
FT                   /note="7"
FT   REPEAT          321..328
FT                   /note="8"
FT   REPEAT          334..341
FT                   /note="9"
FT   REPEAT          346..353
FT                   /note="10"
FT   REGION          1..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          233..484
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          247..353
FT                   /note="10 X 8 AA approximate repeats of R-R-S-R-S-R-S-R"
FT   COMPBIAS        247..309
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        310..326
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        338..381
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        382..484
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         207
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         323
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         325
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         414
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         434
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         447
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         449
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:24275569"
FT   MOD_RES         456
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         464
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         483
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   CROSSLNK        197
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        211
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         420
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043376"
SQ   SEQUENCE   484 AA;  53542 MW;  1211E96DDC0A3182 CRC64;
     MSNTTVVPST AGPGPSGGPG GGGGGGGGGG GTEVIQVTNV SPSASSEQMR TLFGFLGKID
     ELRLFPPDDS PLPVSSRVCF VKFHDPDSAV VAQHLTNTVF VDRALIVVPY AEGVIPDEAK
     ALSLLAPANA VAGLLPGGGL LPTPNPLTQI GAVPLAALGA PTLDPALAAL GLPGANLNSQ
     SLAADQLLKL MSTVDPKLNH VAAGLVSPSL KSDTSSKEIE EAMKRVREAQ SLISAAIEPD
     KKEEKRRHSR SRSRSRRRRT PSSSRHRRSR SRSRRRSHSK SRSRRRSKSP RRRRSHSRER
     GRRSRSTSKT RDKKKEDKEK KRSKTPPKSY STARRSRSAS RERRRRRSRS GTRSPKKPRS
     PKRKLSRSPS PRRHKKEKKK DKDKERSRDE RERSTSKKKK SKDKEKDRER KSESDKDVKQ
     VTRDYDEEEQ GYDSEKEKKE EKKPIETGSP KTKECSVEKG TGDSLRESKV NGDDHHEEDM
     DMSD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024